The Latest Breaking News from EMBC

The MedTech sector’s promising future is driven by technological advances, unceasing demand for medical treatments due to an aging population, and increasing global incidence of diseases. To that end, strong MedTech stocks such as Tactile Systems Technology (TCMD), Electromed (ELMD), and Embecta (EMBC) could be wise portfolio additions in July.…

Increased chronic diseases, rising health awareness, and technological developments are poised to keep the medical equipment industry buoyed for the long term. Therefore, medical equipment stocks STERIS plc (STE), Embecta Corp. (EMBC), and Avanos Medical (AVNS), with noteworthy fundamentals, could be solid buys for a healthy portfolio. Read on….

Despite being a market leader in insulin pen needles and syringes, Embecta Corp (NASDAQ: EMBC) may face challenges ahead, since the markets are already mature and the company has not diversified, according to BofA Securities.

Becton Dickinson and Co's (NYSE:BDX) pure-play diabetes spin-off Embecta Corp (NASDAQ:EMBC) has reported Q2 sales of $274.5 million, down 3.4% on a reported basis, down 1.3% on a constant currency basis. Of the decrease, $6.0 million was attributable to unfavorable effects from foreign currency translation.  Volume unfavorably impacted revenues by approximately $3.7 million, primarily…